Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarshalls Regulatory News (MSLH)

Share Price Information for Marshalls (MSLH)

Share Price is delayed by 15 minutes
Get Live Data
131.60    -4.30 (-3.16%)
Bid:
131.30
Ask:
131.50
Spread: 0.20 (0.152%)
Market Cap: £332.80m
MSLH Live PriceLast checked at - London Stock Exchange

Intraday Marshalls Share Chart

Trading Statement

8 Jan 2010 07:00

RNS Number : 2020F
Marshalls PLC
08 January 2010
Β 

ο»Ώ

Trading Update:Β 8Β JanuaryΒ 2010

Trading in line with expectations

Trading Performance

Marshalls' revenue for theΒ yearΒ ended 31Β DecemberΒ 2009Β was Β£312Β million (2008: Β£378Β million)Β fromΒ  3Β fewer working days compared with 2008. On a like for like basis the underlying daily sales revenueΒ for theΒ fullΒ yearΒ was downΒ 16Β per cent. The second half stabilised with a reduction ofΒ 11Β per centΒ on a like for like basis. Sales to the Public Sector and Commercial market,Β which represent approximatelyΒ 58Β per centΒ of Marshalls'Β sales, were down 18 per cent for the full yearΒ andΒ sales to the Domestic marketΒ were downΒ 13 per cent compared to the prior year.

For the year ended 31 December 2009Β MarshallsΒ expects to announce underlying trading results in line withΒ currentΒ marketΒ expectations.

Current Priorities

The Group continues to focus on driving salesΒ particularlyΒ inΒ product areasΒ where activity is more robust, reducing costs and improving efficiencyΒ whilstΒ maintainingΒ operational flexibilityΒ for the medium term.Β Β If necessary the Group can reduce the cost base further by implementing the temporary "lay off" planΒ agreed in August 2009.

Cash management has been a priority during 2009 and reductions in stock and capital expenditure have ensured that net debtΒ at 31 December 2009Β isΒ slightlyΒ better thanΒ planΒ atΒ approximatelyΒ Β£69 million following the DebentureΒ Stock redemptionΒ referred to below.

The Group continuesΒ to investΒ selectivelyΒ in innovationΒ to reduce operating costs and further extendΒ its competitive advantage through new product development and service solutions. Investment has recently beenΒ madeΒ in polishing technology which will enable the Group to develop new products for both existing and new markets.

Redemption of Debenture

OnΒ 10Β DecemberΒ 2009,Β the Group'sΒ subsidiary, Marshalls Group plc,Β successfully completed the redemptionΒ ofΒ its Β£20 million 11 3/8 per cent Debenture Stock 1992/2014. TheΒ total redemption cost was Β£27.3 million (including costs) and theΒ redemptionΒ premium of Β£7.3 million will be disclosed as an "exceptional" financing cost in the 2009 financial statements.Β Β TheΒ redemption of theΒ DebentureΒ Stock prior to its maturity date willΒ reduceΒ theΒ Group'sΒ interest costsΒ inΒ theΒ short toΒ medium term.

The Group has significant committed facilities in place with a positive spread of medium term maturitiesΒ and has used these facilities to redeem the DebentureΒ Stock.

Outlook

The Group remainsΒ cautious about the short term outlook,Β especially given the latestΒ industry forecasts for 2010 whichΒ continue toΒ predict mid single digit reductions in volume. In the Domestic market,Β installer order books at the end of October 2009Β wereΒ an encouragingΒ 8.1 weeks (2008: 6.4 weeks; 2007: 9.9 weeks)Β and there are signs that confidence is recovering albeit from a low base.Β Β As far as the Public Sector and Commercial market is concerned theΒ order flow remainsΒ subduedΒ although in this marketΒ house building is showing signs of recovery from a low base and there is increased orderΒ activityΒ fromΒ the Olympics.

MarshallsΒ continues to balance short term performance with the need to maintain itsΒ strong market position,Β its reputation for operational excellence,Β itsΒ medium termΒ manufacturing capabilityΒ and its commitment to sustainability.Β Β NoΒ significant capital expenditureΒ is necessaryΒ in the medium term, although the Group continues to innovate andΒ invest selectively toΒ ensure that it continues to beΒ well placedΒ forΒ when markets improve.

Enquiries:

Graham Holden

Chief Executive

Marshalls plc

01484 438900

Ian Burrell

Finance Director

Marshalls plc

01484 438900

Β 

Β 

Β 

Β 

Β 

Jon Coles

Β 

Brunswick Group

0207 404 5959

Kate Miller

Brunswick Group

0207 404 5959

8Β January 2010

Note to the Editor:

AboutΒ Marshalls:

Established in the late 1880s,Β MarshallsΒ is theΒ UK's leading manufacturer of superior natural stone and innovative concrete hard landscaping products, supplying the construction, home improvement and landscape markets. MarshallsΒ provides the product ranges, design services, technical expertise, innovative ideas and inspiration to transform gardens, drives and public and commercial landscapes.

The Group operates its own quarries and manufacturing sites throughout theΒ UK, includingΒ a network ofΒ regional service centres and 2 National manufacturing and distribution sites. As a major plc,Β MarshallsΒ is committed to quality in everything it does, including environmental and ethical best practice and continual improvement in health and safety performance.

Forward-Looking Statements:

Any statements in this release, to the extent that they are forward-looking, are subject to risk factors associated with, amongst other things, the economic and business circumstances occurring from time to time in the markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. More information about the factors that may affect the Group's performance is contained in the Annual Report to shareholders for the year ended 31 December 2008.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBRMITMBBMBLM
Date   Source Headline
14th Jul 202211:51 amRNSDirector/PDMR Shareholding
12th Jul 20227:00 amRNSTrading Statement
11th May 20221:34 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
10th May 20223:14 pmRNSDirector/PDMR Shareholding
10th May 20223:02 pmRNSDirector/PDMR Shareholding
5th May 20229:19 amRNSHolding(s) in Company
3rd May 20224:20 pmRNSHolding(s) in Company
3rd May 20223:09 pmRNSDirector/PDMR Shareholding
3rd May 20223:08 pmRNSDirector/PDMR Shareholding
3rd May 20223:07 pmRNSDirector/PDMR Shareholding
3rd May 20223:06 pmRNSDirector/PDMR Shareholding
3rd May 20223:03 pmRNSDirector/PDMR Shareholding
3rd May 20223:02 pmRNSDirector/PDMR Shareholding
3rd May 20223:01 pmRNSDirector/PDMR Shareholding
3rd May 20223:00 pmRNSDirector/PDMR Shareholding
3rd May 20222:57 pmRNSDirector/PDMR Shareholding
3rd May 20222:53 pmRNSDirector/PDMR Shareholding
3rd May 20229:54 amRNSHolding(s) in Company
29th Apr 20228:25 amRNSTotal Voting Rights
29th Apr 20228:05 amRNSAcquisition
28th Apr 202211:51 amRNSAcquisition
27th Apr 202210:01 amRNSDirector Declaration
7th Apr 20221:50 pmRNSPublication of Prospectus
7th Apr 20227:00 amRNSResults of Accelerated Bookbuild
6th Apr 20224:46 pmRNSProposed Acquisition of Marley Group & Fundraising
5th Apr 20228:58 amRNSAnnual Financial Report
4th Apr 20228:54 amRNSHolding(s) in Company
18th Mar 20223:44 pmRNSDirector/PDMR Shareholding
18th Mar 20223:43 pmRNSDirector/PDMR Shareholding
17th Mar 20227:15 amRNSBoard Appointment
17th Mar 20227:00 amRNSFinal Results
4th Mar 20229:48 amRNSDirector/PDMR Shareholding
4th Feb 20222:42 pmRNSDirector/PDMR Shareholding
31st Jan 202210:29 amRNSDirector Declaration
18th Jan 20227:00 amRNSTrading Statement
5th Jan 20222:31 pmRNSDirector/PDMR Shareholding
14th Dec 202111:26 amRNSDirectorate Change
6th Dec 202110:51 amRNSDirector/PDMR Shareholding
11th Nov 20212:58 pmRNSDirector/PDMR Shareholding
5th Oct 202110:32 amRNSDirector/PDMR Shareholding
1st Oct 20214:03 pmRNSDirector/PDMR Shareholding
29th Sep 20214:09 pmRNSDirector/PDMR Shareholding
21st Sep 20213:54 pmRNSDirector/PDMR Shareholding
21st Sep 20213:53 pmRNSDirector/PDMR Shareholding
7th Sep 20212:06 pmRNSDirector/PDMR Shareholding
20th Aug 20214:57 pmRNSHolding(s) in Company
19th Aug 20217:00 amRNSHalf-year Report
4th Aug 202111:57 amRNSDirector Declaration
19th Jul 20216:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.